TNF-α, particularly, has demonstrated the ability to stimulate keratinocyte proliferation, potentially contributing to cSCC development, while IL-6 and IL-11 can enhance cancer cell survival and migration, thereby bolstering cSCC growth [12,42]. The gene discussed is IL6; the disease is cancer.